The 12 references in paper Zh. Mironova A., E. Vsevolodskaya I., V. Trofimov I., A. Ulitina S., S. Pchelina N., M. Dubina V., S. Gorbunkov D., A. Akopov L., Ж. Миронова А., Е. Всеволодская И., В. Трофимов И., А. Улитина С., С. Пчелина Ф., М. Дубина В., С. Горбунков Д., А. Акопов Л. (2017) “Фармакогенетические и эпигенетические особенности синдрома перекреста бронхиальной астмы и хронической обструктивной болезни легких // Pharmacogenetic and epigenetic features of asthma-COPD overlap syndrome” / spz:neicon:pulmonology:y:2017:i:1:p:7-11

1
Pleasants R.A., Ohar J.A., Croft J.B. et al. Chronic obstructive pulmonary disease and asthma: patient characteristics and health impairment. COPD. 2014; 11 (3): 256–266. DOI: 10.3109/15412555.2013.840571. 11
(check this in PDF content)
2
Xu Q., Leung D.Y., Kisich K.O. Serine-arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor pre-mRNA to glucocorticoid receptor beta in neutrophils.J. Biol. Chem.2003; 278 (29): 27112–27118. DOI: 10.1074/jbc.M300824200.
(check this in PDF content)
3
Li L.B., Leung D.Y., Hall C.F., Goleva E. Divergent expression and function of glucocorticoid receptor βin human monocytes and T-cells. J. Leukoc. Biol.2006; 79 (4): 818–827. DOI: 10.1189/jlb.0805466.
(check this in PDF content)
4
Kelly A., Bowen H., Jee Y.K. et al. The glucocorticoid receptor beta isoform can mediate transcriptional repression by recruiting histone deacetylases. J. Allergy Clin. Immunol. 2008; 121 (1): 203–208. DOI: 10.1016/j.jaci.2007.09.010.
(check this in PDF content)
5
Barnes P.J. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol.2013; 131 (3): 636–645. DOI: 10.1016/j.jaci. 2012.12.1564.
(check this in PDF content)
6
Ito K., Caramori G., Adcock I.M. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.J. Pharmacol. Exp. Ther. 2007; 321 (1): 1–8. DOI: 10.1124/jpet.106.111674.
(check this in PDF content)
7
Strickland I., Kisich K., Hauk P.J. et al. High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J. Exp. Med. 2001; 193 (5): 585–593.
(check this in PDF content)
8
Mercado N., To Y., Ito K., Barnes P.J. Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase δ. J. Pharmacol. Exp. Ther.2011; 337 (2): 465–470. DOI: 10.1124/jpet.110.175950.
(check this in PDF content)
9
Butler C.A., McQuaid S., Taggart C.C. et al. Glucocorticoid receptor b and histone deacetylase 1 and 2 expression in the airways of severe asthma. Thorax. 2012; 67 (5): 392–398. DOI: 10.1136/thoraxjnl-2011-200760.
(check this in PDF content)
10
Welte T., Miravitlles M., Hernandez P. et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.2009; 180 (8): 741–750. DOI: 10.1164/rccm.200904-0492OC.
(check this in PDF content)
11
Magnussen H., Bugnas B., van Noord J. et al. Improvements with tiotropium in COPD patients with concomitant asthma.Respir. Med.2008; 102 (1): 50–56. DOI: 10.1016/ j.rmed.2007.08.003.
(check this in PDF content)
12
To Y., Ito K., Kizawa Y. et al. Targeting phosphoinositide-3kinase-δwith theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.2010; 182 (7): 897–904. DOI: 10.1164/rccm.200906-0937OC.
(check this in PDF content)